Executive Summary
Federal contracts totaling $12.8B highlight massive long-term NASA commitments to space primes like Northrop Grumman ($4.4B propulsion), Boeing ($1.2B SLS), and Lockheed Martin ($2.5B+ potential GEOXO/DAVINCI), signaling stable revenue through 2048 amid 22 bullish signals. IT/services and healthcare/VA awards to Accenture ($1.5B+), Booz Allen ($860M), and CACI ($960M) underscore multi-year demand in student aid, EHRM, and intelligence, with unexercised options exceeding $5B across portfolio. Risks center on execution delays in long-duration deals (avg. end >2026) and fixed-price cost pressures, but 70%+ outlays in mature contracts indicate funding reliability.
Tracking the trend? Catch up on the prior General Federal Contracts digest from January 15, 2026.
Investment Signals(3)
- NASA Space Propulsion/R&D Boom(HIGH)▲
>$7B in NASA contracts to Northrop, Boeing, L3Harris, Lockheed for propulsion, SLS, GEOXO, DAVINCI through 2048 provide decade+ revenue visibility.
- IT Services Multi-Year Lock-Ins(HIGH)▲
>$4B in GSA/VA/DHS/SSA awards to CACI, Booz Allen, ECS Federal, Accenture for intel, EHRM, CDM, telecom through 2030+ with $528M+ options upside.
- Healthcare Admin/Construction Surge(MEDIUM)▲
>$2.1B HHS/VA to Hensel Phelps ($755M build), Novitas ($446M MAC), Booz Allen ($689M EHRM) signal sustained Title IV/Medicare/VA infra spend to 2029.
Risk Flags(3)
- Execution[HIGH RISK]▼
Long durations (22/28 contracts end post-2026, up to 2048) with low outlays in 10 deals ($0-$92M vs. $1B+ obligations) signal potential delays/funding shifts.
- Market[MEDIUM RISK]▼
Firm fixed-price in 11 contracts (e.g., Hensel Phelps $755M, Accenture $1.5B) exposes to cost overruns amid inflation/labor risks.
- Competitive[MEDIUM RISK]▼
Heavy subawards (e.g., Booz Allen 97%, GD IT $294M > obligation) create subcontractor dependencies in 20+ contracts.
Opportunities(3)
- ◆
>$5B unexercised options (e.g., Lockheed $2B GEOXO, CACI $1.5B JIDA, ECS $429M CDM) across 20 contracts offer 30-100% upside if exercised.
- ◆
NASA/HHS long-term extensions (e.g., L3Harris to 2039, Novitas to 2028) in space/health signal recurring revenue in high-barrier sectors.
- ◆
Small/mid-cap winners like ECS ($528M pot.), Defense Unicorns ($89M SBIR) in GSA/DHS IT poised for scaling via set-asides.
Sector Themes(3)
- ◆
7/28 contracts ($7.1B, 55% total value) to NASA primes for propulsion/R&D through 2048 reflect unwavering lunar/GEO investment.
- ◆
12 contracts ($3.5B) in CDM, EHRM, student aid, immigration IT to 2030+ via GSA/VA/DHS highlight cybersecurity/digital transformation spend.
- ◆
6 awards ($2.3B) for CMS MAC, VA EHR/construction, NIH builds to 2029 signal post-pandemic capacity investments.
Watch List(4)
- 👁
{"entity"=>"Northrop Grumman", "reason"=>"$4.4B NASA propulsion to 2026 anchors space revenue; $3.5B unexercised potential.", "trigger"=>"Outlay acceleration >$200M/Q or SLS program expansion"}
- 👁
{"entity"=>"Lockheed Martin", "reason"=>"$2.5B+ GEOXO/DAVINCI options to 2048; dual NASA wins signal franchise.", "trigger"=>"FY26 option exercises >$500M"}
- 👁
{"entity"=>"ECS Federal (ASGN)", "reason"=>"$528M CDM potential to 2030; recent $99M obligation with zero outlay.", "trigger"=>"First $50M outlays confirming execution"}
- 👁
{"entity"=>"Space Sector ETF/Primes", "reason"=>"55% value concentration; long tails to 2048 amid Artemis/SLS ramps.", "trigger"=>"NASA budget >$25B FY27"}
Get daily alerts with 3 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 28 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC